P
PT-141
Research Use Only
Specialty
PT-141
CAS: 189691-06-3
PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist derived from Melanotan II. It acts primarily on MC3 and MC4 receptors in the central nervous system. PT-141 is notable for being the basis of the FDA-approved drug Vyleesi for hypoactive sexual desire disorder. Unlike PDE5 inhibitors that act on the vascular system, PT-141 acts through the nervous system, representing a different mechanism of action in sexual dysfunction research.
Select Size
$49
99%+ Purity
COA Included
Same-Day Ship
US Manufactured
Specifications